
Objective: To develop an optimized formula Jieyu-1 (JY-1) from the herb pair Bupleurum chinense DC.– Paeonia lactiflora Pall., and evaluate its antidepressant efficacy and mechanisms, particularly regulating neuroinflammation, hypothalamic-pituitary-adrenal (HPA) axis dysfunction, and synaptic plasticity impairment. Methods: Data mining was performed on 330 clinical antidepressant prescriptions to identify the core herbal combinations. Based on the core herb pair, JY-1 was rationally designed with adjunctive herbs. Its efficacy was evaluated in lipopolysaccharide (LPS)-induced acute inflammation and chronic unpredictable mild stress (CUMS) mouse models. Depression-like behaviors were assessed via behavioral tests. Serum and cortical HPA axis hormones and proinflammatory cytokines were measured by enzyme-linked immunosorbent assay. Neuronal integrity and microglial polarization were examined by hematoxylin and eosin (H&E), Nissl, and immunofluorescence stainings. Synaptic plasticity- and neuroinflammation-related proteins and mRNAs were assessed by western blotting and quantitative real-time polymerase chain reaction. Flow cytometry was used to analyze M1/M2 phenotypic shifts in LPS-stimulated BV-2 microglia. Molecular docking was performed to predict binding affinities between active compounds and target proteins. Results: Data mining confirmed the Bupleurum – Paeonia pair as the core herb combination. JY-1 significantly alleviated depression-like behaviors, as evidenced by increased sucrose preference ( P LPS = .003; P CUMS = .005) and reduced immobility time (both P < .001). Mechanistically, JY-1 attenuated HPA axis hyperactivity (e.g., serum corticotropin-releasing hormone, P < .001; serum corticosterone, P = .002), reduced neuroinflammation (e.g., cortical IL-6, P LPS = .017; P CUMS = .040), and restored synaptic plasticity by upregulating postsynaptic density protein 95 (PSD95, P LPS = .007). These effects were dose-dependent, and JY-1 exhibited no hepatorenal toxicity. Molecular docking indicated strong binding affinities of its active components to brain-derived neurotrophic factor and PSD95. Conclusion: JY-1 exerts antidepressant effects through coordinated regulation of HPA axis hyperactivity, neuroinflammation with microglial M2 polarization, and synaptic plasticity restoration, in a dose-dependent manner without hepatorenal toxicity.
Objective: To investigate the therapeutic effect and potential mechanisms of Ligusticum chuanxiong Hort. ( L. chuanxiong , Chuan Xiong) and Angelica sinensis (Oliv.) Diels ( A. sinensis , Dang Gui) combined essential oil (CDEO) on testosterone propionate-induced alopecia in C57BL/6 mice. Methods: Symptom co-occurrence analysis was performed using R, and network pharmacology was applied to identify potential therapeutic targets. An androgenetic alopecia model was established through daily subcutaneous injections of testosterone propionate (0.2 mL) at 5 mg/mL for 28 days. Mice received topical treatments with corn oil (model control), minoxidil, or CDEO at concentrations of 1%, 2%, or 5%. Hair regrowth was assessed on days 21 and 28. Western blotting was performed to evaluate the expression of related proteins in the dorsal skin. Results: All CDEO and minoxidil groups demonstrated significantly greater hair regrowth on days 21 and 28 than the model group. Western blotting results revealed that CDEO treatment reduced the expression of androgen receptor ( P = .987), glycogen synthase kinase 3β ( P = .001), 11β-hydroxysteroid dehydrogenase type 1 ( P = .997), and cytochrome P450 17A1 ( P = .003), whereas the low-dose group exhibited partial increases in some markers. No significant changes were observed in AKT or β-catenin expression. Conclusion: CDEO may ameliorate seborrheic alopecia primarily through modulation of steroid hormone-related proteins, which is consistent with the predictions of network pharmacology analysis.
Objective To investigate whether MgAl-layered double hydroxide (LDH) nanosuspension technology can prolong mucosal retention of Kuiyangye (KYY) and thereby improve its therapeutic efficacy against radiation esophagitis (RE) in rats. Methods MgAl-LDH nanosheets were prepared by coprecipitation and loaded with KYY to obtain nano-KYY. An acute RE rat model was established by single 30 Gy irradiation. Rats were divided into control, model, Kangfuxin liquid, nano, KYY, and nano-KYY groups and treated for 7 or 14 days. Esophageal mucosal concentrations of five KYY markers were quantified by high-performance liquid chromatography-mass spectrometry. Esophageal injury was evaluated by hematoxylin-eosin, Masson, and Sirius red staining. Pain-related factors and cytokines were measured by enzyme-linked immunosorbent assay and microarray. Results Compared with the model group, nano-KYY significantly decreased serum prostaglandin E2, substance P, and calcitonin gene-related peptide (all P < .001) and downregulated esophageal TLR4, MyD88, and nuclear factor-κB (NF-κB) (P = .027, P = .009, and P = .033, respectively). Nano-KYY decreased interleukin (IL)-2 and IL-6 (P = .006 and P = .046) and increased IL-10 (P = .033). At day 14, nano-KYY upregulated transforming growth factor-β1, p38MAPK, epidermal growth factor, and fibronectin (P = .003, P = .004, P < .001, and P < .001, respectively) and increased collagen deposition (P < .001). The mucosal concentrations of the five marker compounds were higher in the nano-KYY group than in the KYY group at 5 min, 15 min, and 30 min. At 30 min, emodin remained detectable in the nano-KYY group, with a mean concentration of 2.99 (1.28) ng/mL, but not in the KYY group. Conclusion Nano-KYY enhances the mucosal adhesion and retention of KYY and improves its anti-inflammatory, analgesic, and tissue-repair effects against RE in rats, providing a proof of concept for LDH nanosuspension-mediated delivery of a multi-component traditional Chinese medicine.
Alterations in gut microbial metabolism constitute a major mechanistic bridge connecting dysbiosis to mucosal inflammation and barrier injury in ulcerative colitis (UC). Although previous reviews have addressed microbial composition or global metabolite changes, they frequently group diverse molecules as “microbial metabolites,” obscuring the metabolic steps targeted by Chinese herbal medicine (CHM). To address this gap, we established a three-category framework comprising microbiota-derived metabolites, host–microbiota co-metabolites, and microbiota-modulated host metabolites. Using this framework, we integrated evidence across four metabolic axes: short-chain fatty acids (SCFAs); bile acids; tryptophan; and amino acids, polyamines, and nitrogen metabolism. Current evidence suggests that CHM remodels intestinal metabolism through three complementary modes: provision of microbiota-accessible substrates, microbial biotransformation of CHM constituents, and restoration of the host mucosal metabolic environment. Evidence maturity varies across these axes. SCFA studies increasingly validate microbiota dependence and specific microbial strains. Research on bile acids and tryptophan links metabolites with host receptors. In contrast, amino acid, polyamine, and nitrogen metabolism studies remain dominated by correlative omics analyses and pathway inferences. Microbiota-associated metabolites may be the mechanism linking CHM exposure, microbial function, and host responses. They may also inform metabolite supplementation, reconstruction of endogenous metabolic networks, and combination therapies. However, current evidence is derived mainly from animal models. Few studies report causal associations among CHM composition, functional microbes or enzymes, specific metabolites, and host effects. To transition from compositional associations toward clinically translatable and mechanistically verifiable insights, future studies should integrate standardized CHM preparations, longitudinal multicompartment sampling, targeted absolute quantification, stable-isotope tracing, and staged causal interventions.
Objective To identify post-treatment gut microbial signatures associated with acupuncture for Crohn’s disease (CD)-related abdominal pain and investigate their cross-sectional associations with concurrent clinical phenotypes and microbial functional potential. Methods This secondary exploratory analysis was based on two randomized controlled trials involving 150 patients with CD: 75 in the acupuncture group and 75 in the sham acupuncture group. Gut microbiota analysis included 32 patients with CD (16 per group) and 64 sex- and age-matched healthy controls (HCs). Patients received 36 sessions of acupuncture or sham acupuncture over 12 weeks. Shotgun metagenomic sequencing was performed on week-12 fecal samples from patients with CD and reference samples from HCs. Differential abundance and correlation analyses were integrated to identify core responsive taxa and assess their associations with abdominal pain and microbial functions. Results After 12 weeks, acupuncture significantly improved abdominal pain severity and disease activity compared with sham acupuncture. Eight bacterial species, including Eubacterium ventriosum and Roseburia faecis, were identified as candidate acupuncture-associated taxa based on post-treatment between-group differences and exploratory clinical associations. Their abundance profiles showed greater similarity to those of HCs. These taxa were associated with metabolic pathways, including pantothenate and coenzyme A biosynthesis and biosynthesis of amino acids, and inversely associated with the biofilm formation–Escherichia coli pathway. Exploratory correlations were observed between their post-treatment abundances and concurrent abdominal pain severity; however, these associations did not remain significant after correction for multiple comparisons. Conclusion Our findings showed the candidate microbial signatures associated with acupuncture treatment; however, longitudinal studies are required to determine treatment-related microbiome changes.